Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EMA Recommends Dozens Of Suspensions Over Flawed Synchron Studies
Generic Marketing Authorizations To Be Suspended Following Similar Criticism From US FDA
May 26 2022
•
By
Dave Wallace
Marketing authorizations linked to Synchron data will be suspended • Source: Shutterstock
More from Regulation
More from Policy & Regulation